| Source NDC Code |
|
Target HCPCS Code |
49502-0806-93
YUPELRI 175 mcg/3 ml
|
⇄
|
J7677
REVEFENACIN INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, 1 MICROGRAM
|
| Detail Information |
| Relationship Start Date |
07/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
49502-0806-93
YUPELRI 175 mcg/3 ml
|
⇄
|
J7699
NOC DRUGS, INHALATION SOLUTION ADMINISTERED THROUGH DME
|
| Detail Information |
| Relationship Start Date |
12/14/2018 |
| Relationship End Date |
06/30/2019 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
49502-0806-93
Yupelri
|
⇄
|
J7677
Revefenacin inh non-com 1mcg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|